Approval in the United States Before Other Countries
Comparing approval to other countries offers another measure of approval efficiency. Although regulatory processes differ widely between FDA and those of regulatory agencies in other countries, 19 of the 22 novel drugs approved in 2016 (86%) were approved in the United States before receiving approval in any other country.
Drugs approved first in the U.S. include: Anthim, Axumin, Cinqair, Epclusa, Eucrisa, Exondys 51, Lartruvo, Netspot, Nuplazid, Ocaliva, Rubraca, Spinraza, Taltz, Tecentriq, Venclexta, Xiidra, Zepatier, Zinbryta, Zinplava
86%
Linda will bk nwbo before us approval!!!! imo
Market Data 
Markets 
AI
